rs851689

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2099-108783C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.288 in 151,020 control chromosomes in the GnomAD database, including 6,942 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6942 hom., cov: 31)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0460

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.419 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.2099-108783C>T intron_variant Intron 13 of 23 ENST00000361727.8 NP_054860.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.2099-108783C>T intron_variant Intron 13 of 23 1 NM_014141.6 ENSP00000354778.3

Frequencies

GnomAD3 genomes
AF:
0.288
AC:
43420
AN:
150900
Hom.:
6932
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.424
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.296
Gnomad EAS
AF:
0.0505
Gnomad SAS
AF:
0.272
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.322
Gnomad NFE
AF:
0.246
Gnomad OTH
AF:
0.277
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.288
AC:
43455
AN:
151020
Hom.:
6942
Cov.:
31
AF XY:
0.282
AC XY:
20801
AN XY:
73724
show subpopulations
African (AFR)
AF:
0.424
AC:
17505
AN:
41286
American (AMR)
AF:
0.268
AC:
4067
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
0.296
AC:
1023
AN:
3460
East Asian (EAS)
AF:
0.0502
AC:
257
AN:
5120
South Asian (SAS)
AF:
0.271
AC:
1298
AN:
4794
European-Finnish (FIN)
AF:
0.182
AC:
1871
AN:
10290
Middle Eastern (MID)
AF:
0.323
AC:
95
AN:
294
European-Non Finnish (NFE)
AF:
0.246
AC:
16604
AN:
67580
Other (OTH)
AF:
0.274
AC:
577
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1498
2995
4493
5990
7488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
769
Bravo
AF:
0.299
Asia WGS
AF:
0.172
AC:
597
AN:
3466

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
1.7
DANN
Benign
0.59
PhyloP100
0.046
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs851689; hg19: chr7-147491874; COSMIC: COSV62246251; API